Carri is an experienced leader in Capital Markets Advisory at Karaktero, holding Non-Executive Director and advisory board seats. She specializes in backing seed-stage EU-based digital health companies with a neuroscience focus and seeks investment opportunities from underrepresented regions and backgrounds. With a background in neuroscience research, lifescience finance, and management consulting, Carri brings extensive expertise in equity research, corporate finance, and advising healthcare leaders and boards.